Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Eslicarbazepine Acetate CTF vs TBM Formulations
NCT02283840Phase 1Completed
- Sponsor
- BIAL
- Start
- May 2007
- Primary completion
- Jun 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of eslicarbazepine acetate in epilepsy (6 cohorts), sponsored by BIAL. Primary endpoints: Maximum Plasma Concentration of BIA 2-005, Area Under the Plasma Concentration-time Curve From Time Zero to the Last Sampling Time and 1 more. Started May 2007; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02283840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02283840.